Results 181 to 190 of about 64,386 (306)
Hemorrhagic Events Associated With Direct Oral Anticoagulants: Frequency and Management. [PDF]
Ztati M +3 more
europepmc +1 more source
Cardiovascular-kidney-metabolic interplay in patients with atrial fibrillation receiving direct oral anticoagulants. [PDF]
Chan YH +7 more
europepmc +1 more source
Post-acute care and secondary prevention after ischaemic stroke [PDF]
Higgins, P. +3 more
core +1 more source
Abstract Background and Purpose The absence of the protein dystrophin in Duchenne muscular dystrophy (DMD) leads to progressive muscle weakness, failing regeneration and deregulation of nitric oxide (NO) signalling. We focused on L‐citrulline, a precursor of L‐arginine, required for NO production in muscle, which is reduced in dystrophic mdx muscle ...
Lisamaura Tulimiero +14 more
wiley +1 more source
Perspectives and Experiences of Doctors and Pharmacists on the Clinical Use of Direct Oral Anticoagulants in Saudi Arabia. [PDF]
Aldossari DS +12 more
europepmc +1 more source
ABSTRACT Objectives The objective of this scoping review was to map existing literature on oral health and related care in individuals with Motor Neurone Disease (MND). Specifically, the review aimed to identify barriers and facilitators to maintaining oral hygiene, summarise available clinical guidelines and patient‐facing resources, and examine how ...
Mariam A. Khokhar +3 more
wiley +1 more source
When Atrial Fibrillation Meets Alcoholic Liver Cirrhosis: Can Direct Oral Anticoagulants Bridge the Therapeutic Gap? [PDF]
Marginean IC +6 more
europepmc +1 more source
ABSTRACT Aims To explore sex‐specific heterogeneity in the prognostic discrimination of inflammatory markers for mortality across different glycaemic states. Methods This prospective cohort study included 450 438 participants from the UK Biobank (median follow‐up: 15.3 years), stratified by sex and glycaemic status.
Yawen Zhang +5 more
wiley +1 more source
Impact of direct oral anticoagulants on blood-brain barrier integrity. [PDF]
Sato K +4 more
europepmc +1 more source
ABSTRACT Aims To investigate the association between use of GLP‐1 receptor agonists and incident Parkinson's disease. Material and Methods Cohort study using data from nationwide registers in Denmark, Norway and Sweden and an active‐comparator, new‐user design.
Arvid Engström +10 more
wiley +1 more source

